Treatment Options Post Exposure to COVID-19
Introductory content goes here…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris placerat ullamcorper sem eu sodales. Praesent suscipit mauris nec augue bibendum, ut consequat massa sodales. Proin et lacus enim. Vivamus vulputate luctus ultrices. Quisque consequat porttitor fringilla. Mauris vitae nulla porttitor, gravida diam et, egestas mauris. Mauris convallis metus at urna rutrum, eget hendrerit metus porttitor. Maecenas posuere lorem rhoncus nisi eleifend mollis.
Web Tip: This has the potential to change everything and give us freedom like that already enjoyed by those vaccinated who have a normal immune system.
New COVID-19 Vaccine Clinical Trial Specifically for Those with CLL and Other Blood Cancers
Now there is a new trial (SUPERNOVA) of an updated mix of monoclonal antibodies that hopes to provide durable protection against present and future variants of concerns.
The CLL Nurses Note: The Importance of Advocating for Your Safety in Healthcare Settings
We have for a very long time known that those with CLL / SLL are at risk for having difficulty fighting off infections
FDA Approved Paxlovid for Treatment of COVID-19
Paxlovid is now fully approved for treating mild-to-moderate COVID-19 in adults at high risk for progression to severe COVID-19.
ASH 2022: Dr. Lee Greenberger on Breakthrough COVID-19 Infections in Patients with Blood Cancers
Approx. 10% of blood cancer patients who were vaccinated against COVID-19 reported a breakthrough infection during the original Omicron surge
ASH 2022: Dr. Clare Sun on Methods to Improve the Response to COVID-19 Vaccination in Patients with CLL
Interrupting BTKi therapy around the time of COVID-19 vaccination may result in a more robust antibody response for patients with CLL
ASH 2022: Dr. Andrew Rawstron on B Cells and Antibody Responses to COVID-19 Vaccination in Patients Who Are in Watch and Wait with Untreated CLL
Watch and wait patients with early-stage untreated CLL / SLL produced detectable antibodies in response to COVID-19 vaccination
RECENT NEWS
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.